Cargando…
Aβ1-6(A2V)(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury
Alzheimer’s disease (AD), the leading cause of dementia in older adults, is a double proteinopathy characterized by amyloid-β (Aβ) and tau pathology. Despite enormous efforts that have been spent in the last decades to find effective therapies, late pharmacological interventions along the course of...
Autores principales: | Diomede, Luisa, Zanier, Elisa R., Moro, Federico, Vegliante, Gloria, Colombo, Laura, Russo, Luca, Cagnotto, Alfredo, Natale, Carmina, Xodo, Federica Marta, De Luigi, Ada, Mosconi, Michele, Beeg, Marten, Catania, Marcella, Rossi, Giacomina, Tagliavini, Fabrizio, Di Fede, Giuseppe, Salmona, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611578/ https://www.ncbi.nlm.nih.gov/pubmed/37198260 http://dx.doi.org/10.1038/s41380-023-02101-3 |
Ejemplares similares
-
Nonphosphorylated tau slows down Aβ(1–42) aggregation, binds to Aβ(1–42) oligomers, and reduces Aβ(1–42) toxicity
por: Beeg, Marten, et al.
Publicado: (2021) -
A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection
por: Beeg, Marten, et al.
Publicado: (2023) -
Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
por: Di Fede, Giuseppe, et al.
Publicado: (2016) -
Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
por: Catania, Marcella, et al.
Publicado: (2019) -
The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42
por: Gautieri, Alfonso, et al.
Publicado: (2019)